Characterization of TolC efflux pump proteins from Pasteurella multocida.

Antimicrobial Agents and Chemotherapy
Tamas HatfaludiB Adler

Abstract

Two TolC homologs, PM0527 and PM1980, were identified for Pasteurella multocida. A pm0527 mutant displayed increased susceptibility to a range of chemicals, including rifampin (512-fold) and acridine orange (128-fold). A pm1980 mutant showed increased susceptibility to rifampin, ceftazidime, and vancomycin.

References

Jul 1, 1991·Agricultural and Biological Chemistry·R UtsumiM Noda
Oct 1, 1995·Journal of Bacteriology·C WassifR Belas
Dec 1, 1996·Computer Applications in the Biosciences : CABIOS·N GaltierC Gautier
Jun 22, 1999·Journal of Molecular Biology·Y ZhangK Geider
Mar 28, 2001·EMBO Reports·C AndersenV Koronakis
Mar 30, 2001·Veterinary Microbiology·M CárdenasUNKNOWN Molecular Microbiology Group
Jul 17, 2001·Current Opinion in Cell Biology·C AndersenV Koronakis
Jan 18, 2002·Antimicrobial Agents and Chemotherapy·Xian-Zhi LiKeith Poole
Jun 19, 2002·Antimicrobial Agents and Chemotherapy·Jun LinQijing Zhang
Feb 3, 2005·The Journal of Biological Chemistry·Luca FedericiAdrian R Walmsley
Apr 14, 2006·Cellular Microbiology·Anthony M BuckleyLaura J V Piddock
Jun 1, 2006·Microbiology·Georg Polleichtner, Christian Andersen
Jun 1, 2006·Proteins·Arun S KonagurthuArthur M Lesk
Jul 18, 2006·Nature Reviews. Microbiology·Laura J V Piddock
Jan 20, 2007·Microbial Cell Factories·Keith Al-HasaniBen Adler

❮ Previous
Next ❯

Citations

Aug 15, 2009·Drugs·Xian-Zhi Li, Hiroshi Nikaido
Mar 4, 2010·Veterinary Microbiology·Tamás HatfaludiBen Adler
Mar 20, 2015·Clinical Microbiology Reviews·Xian-Zhi LiHiroshi Nikaido

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.